KELOWNA, B.C. – The Valens Firm Inc. (TSX: VLNS) (NASDAQ: VLNS) (the “Company,” “The Valens Company” or “Valens”), a number one producer of hashish merchandise, introduced as we speak two agreements with PMI Mexico, a subsidiary of Merger Group, one of many major drug suppliers of the Mexican authorities. Beneath the primary settlement, Valens will provide CBD for PMI’s ongoing pharmacokinetic (PK) stage medical trials, that are centered on anti-inflammatory functions of medical-grade, nano-water emulsified CBD oil. The medical trial has already been permitted by The Medical Ethics Board of Mexico. The medical trial, which is about to start as soon as Valens shipments arrive in Q1 of 2022, can be performed throughout non-public hospitals in Mexico. On the conclusion of the trial, Valens would be the sole producer and international distributor in collaboration with PMI.
Beneath the second settlement, Valens will manufacture and distribute CBD-infused and uninfused PredilifeⓇ merchandise globally whereas PMI can be liable for distribution of the PredilifeⓇ merchandise in Mexico. Predilife is an agave-based prebiotic powder that has been submitted as a drug grasp file” (DMF) to the FDA. Valens will manufacture the merchandise at its Inexperienced Roads facility in Florida, the place it is going to be infused with CBD as required after which packaged and distributed via Valens’ third-party provider channels throughout Asia, U.S., Latin America and Mexico. The formulation can be provided in each powder and liquid sachets, initially for human consumption, with animal variations deliberate for the second half of 2022.
“The relationship we have built with PMI Mexico marks an important milestone for Valens’ international expansion and the beginning of our Central and Latin America strategy,” stated Tyler Robson, CEO, Chair & Co-founder of The Valens Firm. “Predilife has significant and unique versatility in terms of reach and market potential given it can be consumed infused or uninfused with CBD. This enables unimpeded distribution of the product regardless of local cannabis regulations, providing Valens access to several international markets. This agreement diversifies our global strategy and increases our revenue streams through creative, non-traditional strategies that separate us from our peers.”
Gustavo Bustillo PhD, Scientific Director of PMI stated, “In Valens we found a technological partner that was capable of providing us not only the required quality but also the technical support and necessary documents needed to comply with pharmaceutical regulations. We look forward to initiating our commercial relationship and watching it expand globally over the coming years.”
At Valens, it’s Private.
About The Valens Firm
The Valens Firm is a worldwide chief within the end-to-end growth and manufacturing of progressive, cannabinoid based mostly merchandise. The Valens Firm is targeted on being the associate of selection for main Canadian and worldwide hashish manufacturers by offering best-in-class, proprietary companies together with CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and product growth and customized manufacturing. Valens is the most important third-party extraction firm in Canada with an annual capability of 425,000 kg of dried hashish and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is within the technique of changing into European Union (EU) Good Manufacturing Practices (GMP) compliant. The Valens Firm presently provides a variety of product codecs, together with tinctures, two-piece caps, delicate gels, oral sprays and vape pens in addition to drinks, concentrates, topicals, edibles, injectables, pure well being merchandise and has a robust pipeline of next-generation merchandise in growth for future launch. Lastly, The Valens Firm’s wholly-owned subsidiary Valens Labs is a Well being Canada licensed ISO 17025 accredited hashish testing lab offering sector-leading analytical companies and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Primarily based Science. For extra data, please go to https://thevalenscompany.com. The Valens Firm’s investor deck could be discovered particularly at https://thevalenscompany.com/investors/.
About Merger Group
Merger Group, based mostly in Newark, Delaware is a pioneer in creating medicine and dietary supplements with over 20 years of expertise throughout the pharmaceutical trade. Merger Group is devoted to the analysis, innovation and growth of each medication and pure and natural merchandise which may also help progress the existence of its customers by enhancing their well being and well-being. PMI Mexico, a division of Merger Group, is a subsidiary devoted to the analysis, medical research, evaluation and integration of technical documentation to acquire well being information, coordination of logistics and import permits.